Thanks WAG - appreciate the reply. Yes silly me I had it in my head that Acadia was Rett only, not ALL indications. I assume thus that in the years ahead as 2566 is further developed for other syndromes/rare diseases, this is further incremental upside for NEU but the onus is on Acadia driving this (rather than NEU).
Thanks WAG - appreciate the reply. Yes silly me I had it in my...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.20 |
Change
-0.010(0.08%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.20 | $12.39 | $12.10 | $2.106M | 172.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 750 | $12.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.35 | 500 | 1 |
View Market Depth
| Last trade - 14.10pm 26/12/2024 (20 minute delay) ? |
| NEU (ASX) Chart |
